SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000912282-18-000168
Filing Date
2018-12-26
Accepted
2018-12-26 17:21:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 angiosoma-atwood13d_122618.htm SC 13D 522314
2 JOINT FILING AGREEMENT ex99_1.htm EX-99.1 48053
3 TRADING DATA ex99_2.htm EX-99.2 36545
  Complete submission text file 0000912282-18-000168.txt   608214
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Subject) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13D | Act: 34 | File No.: 005-89519 | Film No.: 181253222
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5000 RIVERSIDE DR STE100E IRVING TX 75039
Business Address
Atwood Brent (Filed by) CIK: 0001753747 (see all company filings)

Type: SC 13D